Login / Signup
Industries
Technology
Energy
Media
Finance
Green Issues
China
All Concepts
Metals
Energy
Meats
Grains
Softs
ETFs
Indices
Currencies
Geographies
Exchanges
Rates
How To Invest
Personal Finance
Options 101
Definitions
close
close
Send us Feedback
Mylan Laboratories (MYL)
SUMMARY
BULLS
BEARS
DATA CENTRAL
STOCK CHART
BALANCE SHEET
INCOME STMT
CASH FLOW
Key Metrics for MYL as compared to
Top Competitors
Drugs - Generic
Pharma & Healthcare
Pharma & healthcare
All values TTM unless otherwise noted (*)
INDUSTRY METRICS
No data.
Revenue
Net Income
Operating Income
INCOME STATEMENT (
See all
)
Revenue
►
4.94B
AVG
EBITDA
►
813M
AVG
Net Income
►
-86.8M
VERY LOW
Revenue Growth
►
10.4%
AVG
Net Income Growth
►
13.4%
AVG
Operating Margin
►
10%
AVG
Net Margin
►
3.9%
LOW
Revenue, Net Income, and Net Margin
Revenue, Gross Profit, and Gross Margin
Operating Income
Ebit
Income Before Taxes
Net Income from Continuing Ops
Interest vs Continuing Income
Interest Coverage
Operating Expenses
Research & Development
SG&A
Amortization & Depreciation
BALANCE SHEET (most recent quarter) (
See all
)
Debt / Equity
►
2.52
VERY HIGH
Current Ratio
►
2.06
AVG
Quick Ratio
►
1.35
AVG
Interest Coverage Ratio
►
1.56
AVG
Book Value Per Share
►
10.0
Cash Per Share
►
2.13
Loading...
STOCK SUMMARY
Open
17.74
Day Range
17.31
-
17.63
52 Week Range
8.69
-
18.10
Volume
5.33M
Avg Volume (3 mo)
7.13M
Shares Outstanding
299M
Market Cap
5.36B
VALUATION
Price to Earnings (P/E)
►
27.8
HIGH
Price to Book (P/B)
►
1.74
AVG
Price to Sales (P/S)
►
1.08
AVG
Return on Assets (ROA)
►
2.3%
LOW
Return on Equity (ROE)
►
-2.9%
VERY LOW
EV/EBITDA
►
13.7
AVG
Dividend Yield
0%
AVG
ANALYST RECOMMENDATIONS
OWNERSHIP
Net Insider Buying 3mo
0%
Net Insider Buying 6mo
0%
Net Insider Buying 1yr
0.8%
Held by insiders
2.1%
Held by institutions
107.8%
No Sales Breakout Data.